Related posts:

1. Patients Treated With Sunitinib And Sorafenib Respond To Flu Vaccine Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared, according to a study in Clinical Cancer Research, a journal of the American Association for Cancer Research. Keith Flaherty, M.D., director of developmental therapeutics at the Massachusetts General Hospital […]...
2. Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
3. Share of Cost, New Rules to Require Equal Visitation Rights for All Hospital Patients Share of Cost, New Rules to Require Equal Visitation Rights for All Hospital Patients: The Centers for Medicare & Medicaid Services has issued new rules for Medicare- and Medicaid-participating hospitals that protect patients’ right to choose their own visitors during a hospital stay, including a visitor who is a same-sex domestic partner.  The rules require hospitals […]...
4. Share of Cost, Mass. Docs Will Soon Track Patients Who Abuse Prescription Drugs; Wis. Catholic Church Employees Now Eligible For Birth Control The Boston Globe: “With a few computer keystrokes, Massachusetts physicians will soon be able to identify patients who travel from clinic to clinic in pursuit of potent prescription drugs that feed lethal addictions....
5. Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
6. Share of Cost, For Acid Reflux Disease Patients, Esophageal Cancer Risk Lower Than Expected Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
7. Share of Cost, ASGS Issues Position Statement Supporting Transoral Fundoplication For Select GERD Patients EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the American Society of General Surgeons (ASGS) recently issued a position statement in support of transoral fundoplication for the surgical treatment of gastroesophageal reflex disease (GERD)....
8. Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
9. Diabetes Patients Who Undergo Bariatric Surgery Require Fewer Medications Type 2 diabetes patients who underwent bariatric surgery appear to require significantly less medication and incur considerably lower health costs, says a report published in this month’s issue of Archives of Surgery, a JAMA/Archives journal. Bariatric surgery is a surgical procedure on the stomach and/or intestines to help extremely obese people lose weight – it […]...
10. Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients: A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart’s function while the patient waits for a heart transplant. […]...
11. Anxiety Increases Risk Of Complications For Heart Disease Patients Patients with heart disease who also suffer from an anxiety disorder have a significantly higher risk of having a heart attack, heart failure, stroke and death, compared to other heart disease patients, according to Dutch scientists. You can read about this study in the peer-reviewed medical journal Archives of General Psychiatry…...
12. Advanced Technique For Treating Esophageal Lesions Deemed Safe And Effective In European Endoscopy Journal An increasingly popular technique for removing lesions associated with Barrett’s esophagus has been deemed a safe and effective treatment option in a study of more than 1,000 resections published this month in the European journal Endoscopy....
13. Modern Treatments For GERD Effective At Achieving Long-Term Remission For Most Patients In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA....
14. Findings On Cell Interactions Published By U. Iowa Biologists Two University of Iowa biologists have published a paper on how cells make specific interactions during development — in the hope of one day learning more about human developmental disorders — in the journal Proceedings of the National Academy of Sciences....
15. First Patient Enrolled And Treated In The U.S. For EndoGastric Solutions’ Randomized Study Of Transoral Incisionless Fundoplication (TIF) EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the first patient has been enrolled and treated in the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial). The RESPECT trial was designed by co-principle investigators Dr. John Hunter, Chairman of Surgery, Oregon Health & Science University, and […]...